Evidence
Clinical Evidence
Only AEROCHAMBER PLUS® FLOW-VU® chambers were equivalent to the reference device data listed in virtually all innovator inhalers currently approved in the US and European markets. Differences in chamber design, materials and function mean that chambers should not be automatically considered interchangeable.
Read the post:Clinical Evidence
Evidence
Comparing Breath Actuated and Breath Enhanced Jet Nebulizers for the Delivery of Tobramycin
Nebulization is the mainstay of care for patients requiring inhaled antibiotic therapy in association with pulmonary diseases such as cystic fibrosis (CF), bronchiectasis and chronic obstructive lung disease (COPD). Breath actuated (BA) technology offers more consistent dose delivery1 and the reduction of fugitive emissions2 into the care environment.
Read the post:Comparing Breath Actuated and Breath Enhanced Jet Nebulizers for the Delivery of Tobramycin